JAKARTA - The Japanese Ministry of Health approved dexamethasone as part of the treatment for COVID-19. Tests in the UK have shown the drug can reduce the death rate in hospitalized COVID-19 patients.
The cheap steroid that is very widely used will be used as a treatment option along with remdesivir. Reported by the New York Times, this has even been listed in the handbook of Japanese health workers as a revision of the previous edition.
The Japanese government is optimistic. This revision has been widely announced to local media, Wednesday, July 22. Reportedly, in a trial last month, British researchers found a positive reaction to dexamethasone in helping cure COVID-19 patients.
In fact, dexamethasone is said to be the first drug to save the lives of COVID-19 patients. The findings that the researchers call a major breakthrough in the new coronavirus resistance.
The Japanese authorities, on the same occasion, also announced which companies would produce drugs. Japan's Nichi-Iko Pharmaceutical Co is one they name.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
Most Popular Tags
#Prabowo Subianto #golkar #OTT KPK #Pilkada Dki #online gamblingPopular
